Provided by Tiger Trade Technology Pte. Ltd.

Jaguar Animal Health

4.53
-0.4700-9.40%
Post-market: 4.530.00000.00%16:12 EDT
Volume:569.68K
Turnover:2.61M
Market Cap:23.41M
PE:0.00
High:4.94
Open:4.82
Low:4.37
Close:5.00
52wk High:1,152.61
52wk Low:2.35
Shares:5.17M
Float Shares:436.90K
Volume Ratio:0.06
T/O Rate:130.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2,338.1604
EPS(LYR):-12,059.1987
ROE:-548.83%
ROA:-38.04%
PB:3.54
PE(LYR):0.00

Loading ...

Jaguar Health Unit Napo Sponsors Pediatric Intestinal Failure Panel as Crofelemer Studies Continue

Reuters
·
Oct 06

NASDAQ Trade Halt Volatility Trading Pause at 09:52 Am

Reuters
·
Oct 05

Jaguar Health announces special stock dividend

TIPRANKS
·
Oct 05

Jaguar Health Declares Special Stock Dividend of Series R Convertible Preferred Shares

Reuters
·
Oct 05

Jaguar Health Declares Special Stock Dividend of Series R Preferred, Convertible into 5 Common Shares

Reuters
·
Oct 03

Jaguar Health Open-Label Crofelemer Study in Adult SBS-if Patients Accepted for ACG 2026 Presentation

Reuters
·
Sep 29

Jaguar Health Issues 481,584 Shares to Cut USD 3.4 Million from Streeterville Note Balance

Reuters
·
Sep 28

Jaguar Animal Health trading halted, volatility trading pause

TIPRANKS
·
Sep 25

NASDAQ Trade Halt Volatility Trading Pause at 09:32 Am

Reuters
·
Sep 25

Jaguar Health - May Sell up to $9.82 Mln of Common Stock Under Atm Program - SEC Filing

THOMSON REUTERS
·
Sep 24

Jaguar Animal Health Reduces Debt Through Equity Exchange

TIPRANKS
·
Sep 24

Jaguar Health Issues 547,898 Shares to Streeterville in Exchange for $5.05 Million 2025 Note Reduction

Reuters
·
Sep 24

NASDAQ Trade Halt Volatility Trading Pause at 12:35 Pm

Reuters
·
Sep 24

Top Premarket Decliners

MT Newswires Live
·
Sep 23

Top Midday Gainers

MT Newswires Live
·
Sep 23

NASDAQ Trade Halt Volatility Trading Pause at 12:06 Pm

Reuters
·
Sep 23

Jaguar Health receives fee waivers from FDA

TIPRANKS
·
Sep 22

Jaguar Health : FDA Grants Pdufa Fee Waiver for Mytesi for 2027 Fiscal Year

THOMSON REUTERS
·
Sep 22

Jaguar Health : Targets Nda Filing for Crofelemer Powder for Mvid Mid-2027

THOMSON REUTERS
·
Sep 22

Jaguar Health Wins FDA Fee Waivers for Mytesi, Canalevia for Fiscal 2027

Reuters
·
Sep 22